One-Level ESPB (n:30) | Bi-Level ESPB (n:30) | p | |
---|---|---|---|
Morphine Consumption via PCA (mg)β | 12.0 (8.0–23.0) | 10.0 (6.00–13.0) | 0.113 |
MME consumption (mg)β | 13.5 (8.00-25.7) | 10.5 (6.00–15.0) | 0,055 |
Additional Analgesic Use n (%)δ | 11 (36.7%) | 5 (16.7%) | 0.080 |
Nausea n (%)δ | 2 (6.66%) | 1 (3.33%) | 0.999 |
Vomiting n (%) | - | - | - |
Allergic reactions n (%) | - | - | - |
Respiratory depression n (%) | - | - | - |
Hypotension n (%) | - | - | - |
Urinary retention n (%) | - | - | - |
Itching n (%) | - | - | - |